These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 3963588)

  • 1. Neutrophil chemotaxis in rhesus macaques (Macaca mulatta).
    Gonder JC; Thomas JM; Payne ES
    Am J Vet Res; 1986 Apr; 47(4):860-2. PubMed ID: 3963588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of chemotactic activity developed by neutrophils from rheumatoid arthritis patients.
    Bostan M; Constantin MC; Nicolau A; Hirt M; Galatiuc C; Matei I; Braşoveanu LI; Iordăchescu D
    Roum Arch Microbiol Immunol; 2002; 61(4):243-58. PubMed ID: 15055258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil chemotactic heterogeneity to N-formyl-methionyl-leucyl-phenylalanine detected by the under-agarose assay.
    Quitt M; Torres M; McGuire W; Beyer L; Coates TD
    J Lab Clin Med; 1990 Feb; 115(2):159-64. PubMed ID: 2299263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition by phenytoin of chemotactic factor - stimulated neutrophil functions.
    Webster RO; Goldstein IM; Flick MR
    J Lab Clin Med; 1984 Jan; 103(1):22-33. PubMed ID: 6317777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotaxis of horse polymorphonuclear leukocytes to N-formyl-L-methionyl-L-leucyl-L-phenylalanine.
    Zinkl JG; Brown PD
    Am J Vet Res; 1982 Apr; 43(4):613-6. PubMed ID: 7073083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of neutrophil chemotactic function in breast cancer patients treated with chemotherapy.
    Mendonça MA; Cunha FQ; Murta EF; Tavares-Murta BM
    Cancer Chemother Pharmacol; 2006 May; 57(5):663-70. PubMed ID: 16133528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotaxis of radiolabeled equine neutrophils.
    Camp CJ; Leid RW
    Am J Vet Res; 1982 Mar; 43(3):397-401. PubMed ID: 7073055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsteroidal anti-inflammatory drug as tools for analysis of neutrophil functions.
    Périanin A; Giroud JP; Hakim J
    Biomed Pharmacother; 1987; 41(6):315-21. PubMed ID: 3446289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An indirect bioluminescence method for the quantitative measurement of polymorphonuclear cell chemotaxis.
    Partsch G; Schwarzer C
    J Biolumin Chemilumin; 1991; 6(3):159-67. PubMed ID: 1660670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospholipase D-dependent and -independent p38MAPK activation pathways are required for superoxide production and chemotactic induction, respectively, in rat neutrophils stimulated by fMLP.
    Azuma Y; Kosaka K; Kashimata M
    Eur J Pharmacol; 2007 Jul; 568(1-3):260-8. PubMed ID: 17560994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotactic factor induced neutrophil shape changes in whole blood. A comparison of adults and neonates.
    Davis BH; Bronspiegel N; Krause PJ; Clark DA
    Ann Clin Lab Sci; 1985; 15(6):495-503. PubMed ID: 4062230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil function in the dog: shape change and response to a synthetic tripeptide.
    Stickle JE; Kwan DK; Smith CW
    Am J Vet Res; 1985 Jan; 46(1):225-8. PubMed ID: 3970429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homologous priming in chemotactic peptide-stimulated neutrophils.
    Bellavite P; Chirumbolo S; Lippi G; Guzzo P; Santonastaso C
    Cell Biochem Funct; 1993 Jun; 11(2):93-100. PubMed ID: 8391938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of granulocyte deformability following exposure to chemotactic stimuli.
    Pécsvárady Z; Fisher TC; Fabók A; Coates TD; Meiselman HJ
    Blood Cells; 1992; 18(2):333-52; discussion 353-8. PubMed ID: 1450430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation.
    Solomkin JS; Jenkins MK; Nelson RD; Chenoweth D; Simmons RL
    Surgery; 1981 Aug; 90(2):319-27. PubMed ID: 7256544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotactic peptide binding by intact neutrophils from human neonates.
    Strauss RG; Snyder EL
    Pediatr Res; 1984 Jan; 18(1):63-6. PubMed ID: 6322097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrasting responses to multiple chemotactic stimuli in transendothelial migration: heterologous desensitization in neutrophils and augmentation of migration in eosinophils.
    Kitayama J; Carr MW; Roth SJ; Buccola J; Springer TA
    J Immunol; 1997 Mar; 158(5):2340-9. PubMed ID: 9036983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Removal of human polymorphonuclear leukocyte surface sialic acid inhibits reexpression (or recycling) of formyl peptide receptors. A possible explanation for its effect on formyl peptide-induced polymorphonuclear leukocyte chemotaxis.
    Perez HD; Elfman F; Lobo E
    J Immunol; 1987 Sep; 139(6):1978-84. PubMed ID: 3624873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences among primates in defence against infection: sensitivity of polymorphonuclear leukocytes to fMet-Leu-Phe.
    Suzuki K; Asaoka K; Takahashi K; Fujikura T
    Cell Biochem Funct; 1985 Oct; 3(4):297-303. PubMed ID: 3013451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A monoclonal antibody-inhibiting FMLP-induced chemotaxis of human neutrophils.
    Cotter TG; Keeling PJ; Henson PM
    J Immunol; 1981 Dec; 127(6):2241-5. PubMed ID: 7053244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.